Teva Pharmaceutical Industries (TEV) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock TEV Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period Stocks Generating Improved Relative Strength: Teva Pharmaceutical ADRJune 9 at 12:28 PM | msn.comTeva 2024 Healthy Future Report: Health System Strengthening and Capacity BuildingJune 6, 2025 | finance.yahoo.comTeva Pharmaceutical Industries Limited (TEVA) Study Finds Gaps in Tardive Dyskinesia Care at Long-Term FacilitiesMay 31, 2025 | msn.comTeva Pharmaceutical Industries Limited (TEVA) Highlights Long-Acting Injectable Advancements for Schizophrenia at 2025 Psych CongressMay 31, 2025 | msn.comTeva Pharmaceutical Industries Ltd: Teva Celiac Disease Candidate Granted Fast Track Designation by US FDAMay 27, 2025 | finanznachrichten.deTeva Pharmaceutical Industries Limited (TEVA) Wins FDA Fast Track for Celiac Disease Drug TEV-53408May 27, 2025 | msn.comTeva Pharmaceutical Industries (NYSE:TEVA) Upsizes Senior Notes Offering to US$2.3 BillionMay 21, 2025 | finance.yahoo.comTeva Pharmaceutical Industries Ltd: Teva Announces $2,000,000,000 (Equivalent) Debt Tender Offers For Notes Due 2026-2031May 19, 2025 | finanznachrichten.deMoody’s upgrades Teva’s CFR to Ba1, maintains stable outlookMay 15, 2025 | investing.comWhy Teva Pharmaceutical Industries Limited (TEVA) Is the Best Affordable Stock Under $20 to BuyMay 15, 2025 | msn.comJP Morgan Upgrades Teva Pharmaceutical Industries Limited - Depositary Receipt () (TEVA)May 14, 2025 | msn.comWhy Teva Pharmaceuticals Stock Blasted 6% Higher TodayMay 12, 2025 | finance.yahoo.comTeva Pharmaceutical Industries Ltd (TEVA) Q1 2025 Earnings Call Highlights: Strong Growth in ...May 8, 2025 | finance.yahoo.comTeva to Host Innovation & Strategy Day on Thursday, May 29 in New York CityMay 7, 2025 | uk.finance.yahoo.comTeva Pharma shares rise as Q1 earnings beat estimates, guidance raisedMay 7, 2025 | au.investing.comTeva rises as forex impact drives Q1 revenue missMay 7, 2025 | msn.comTeva Pharm first-quarter profit rise tops estimatesMay 7, 2025 | msn.comTeva and Alvotech Announce FDA Approval of Interchangeability for SELARSDI (ustekinumab-aekn) with Stelara (ustekinumab)May 6, 2025 | finanznachrichten.deProtalix BioTherapeutics' CFO Rubin to LeaveApril 23, 2025 | marketwatch.comIndia, China reciprocal tariffs will impact pharma, biotech industriesApril 3, 2025 | msn.comTeva Pharmaceutical Industries (TEVA) Stock ForecastsApril 3, 2025 | finance.yahoo.comBig Pharma drops sharply ahead of Trump’s tariff announcementApril 2, 2025 | msn.com8 Most Undervalued Healthcare Stocks To Buy According To AnalystsApril 1, 2025 | insidermonkey.comPiper Sandler Keeps Their Buy Rating on Teva Pharmaceutical (TEVA)March 31, 2025 | markets.businessinsider.comJustice for Overcharged Patients: Pennsylvania Secures $39.1M in Fight Against Greedy Pharma SchemeMarch 27, 2025 | msn.comWas Jim Cramer Right About Teva Pharmaceutical Industries (TEVA)?March 22, 2025 | msn.comDrugmakers agree to participate in second round of price negotiationsMarch 15, 2025 | msn.comTeva Upgrades Its 4PL Model, Enhancing Medicine Accessibility for Patients with Kerry PharmaMarch 14, 2025 | finance.yahoo.comThis Is What Whales Are Betting On Teva Pharmaceutical IndusMarch 7, 2025 | benzinga.comTeva price target lowered to $20 from $23 at BofAMarch 6, 2025 | markets.businessinsider.comIs Teva Pharmaceuticals Industries Limited (TEVA) the Best Weight Loss Drug Stock to Buy According to Analysts?March 1, 2025 | msn.comTeva/Alvotech follow Amgen in launching biosimilar for J&J’s StelaraFebruary 21, 2025 | msn.comIs Teva Pharmaceutical (TEVA) Trading at a Discount?February 19, 2025 | msn.comTeva EVP Mark Sabag sells $2.89 million in sharesFebruary 14, 2025 | msn.comEvercore ISI Sticks to Their Buy Rating for Teva Pharmaceutical (TEVA)February 3, 2025 | markets.businessinsider.comTeva Pharmaceutical Industries Ltd (TEVA) Q4 2024 Earnings Call Highlights: Strong Revenue ...January 31, 2025 | finance.yahoo.comBofA cuts TEVA stock price target to $23, maintains Buy ratingJanuary 30, 2025 | msn.comTeva sees FY25 EPS $2.35-$2.65, consensus $2.47January 29, 2025 | markets.businessinsider.comTeva Pharmaceutical shares tumble as 2025 outlook disappointsJanuary 29, 2025 | msn.comTeva Swings to 4Q Loss as Revenue FallsJanuary 29, 2025 | marketwatch.comCorruption investigation opened into Teva following employee's complaintJanuary 29, 2025 | msn.comCorruption investigation opened into Teva following employee's complaintJanuary 29, 2025 | msn.comTeva Pharm Q4 tops estimates on strong sales of its own drugsJanuary 29, 2025 | reuters.comTeva Pharmaceuticals: Promising Growth Prospects and Buy Rating ReaffirmedJanuary 23, 2025 | markets.businessinsider.comTeva price target raised to $30 from $28 at UBSJanuary 23, 2025 | markets.businessinsider.comUBS lifts Teva stock price target to $30, maintains Buy ratingJanuary 23, 2025 | msn.comTeva sues CMS over Medicare drug price negotiationsJanuary 19, 2025 | seekingalpha.comTeva enters pact with Klinge Biopharma, Formycon to commercialize FYB203January 13, 2025 | markets.businessinsider.comTeva inks partnership with Klinge to launch Eylea biosimilar in EuropeJanuary 13, 2025 | msn.comTeva Collaborates With Klinge, Formycon For Semi-exclusive Commercialization Of FYB203January 13, 2025 | markets.businessinsider.com Get Teva Pharmaceutical Industries News Delivered to You Automatically Sign up to receive the latest news and ratings for TEV and its competitors with MarketBeat's FREE daily newsletter. Email Address TEV Media Mentions By Week TEV Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TEV News Sentiment▼0.700.87▲Average Medical News Sentiment TEV News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TEV Articles This Week▼22▲TEV Articles Average Week Get Teva Pharmaceutical Industries News Delivered to You Automatically Sign up to receive the latest news and ratings for TEV and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Genfit News Merck KGaA News ad pepper media International News Evotec News Fielmann Group News Fresenius SE & Co. KGaA News Sanofi News Sartorius Stedim Biotech News Siemens Healthineers News Bayer Aktiengesellschaft News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (FRA:TEV) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Teva Pharmaceutical Industries Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Teva Pharmaceutical Industries With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy TEV Stock Free TEV Stock Alerts